SELLAS Life Sciences SLS
NASDAQ SLS
$11.51 -0.08 (-0.69%)
At close: Sep 29, 2026 · 4:00 PM EDT

SELLAS Life Sciences (SLS) Gross Margin (2013 - 2022)

Updated

SELLAS Life Sciences (SLS) reported Gross Margin of 90.00% for FY2022, down 7.37 percentage points from 97.37% in FY2021.

Analysis

SELLAS Life Sciences (SLS) Gross Margin (2013 - 2022) Analysis & Trends

Dating back to FY2013, SELLAS Life Sciences' Gross Margin record includes 5 years.

  • The FY2022 figure ranks as the lowest annual Gross Margin since FY2014.
  • According to Business Quant data, Gross Margin came in at 97.37% in FY2021 (-2.63 pp) and 100.00% in FY2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 68.19%
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 74.74%
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 73.54%
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 78.02%
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 83.60%
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 72.04%
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 79.76%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 72.78%
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 85.33%
10 SELLAS Life Sciences 2.34 Bn 2.34 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2022 90.00%
Jun 30, 2021 94.74%
Mar 31, 2021 98.25%
Dec 31, 2020 100.00%
Jun 30, 2015 86.16%
Mar 31, 2015 85.71%
Dec 31, 2014 85.04%
Sep 30, 2014 84.75%
Jun 30, 2014 85.11%
Mar 31, 2014 84.77%
Dec 31, 2013 91.80%
Sep 30, 2013 53.64%
Jun 30, 2013 100.00%
Mar 31, 2013 100.00%
API Access

SELLAS Life Sciences Gross Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gross-margin&ticker=SLS&period=max&api_key=YOUR_API_KEY